PYMNTS.com November 29, 2024

Chief operating officers (COOs) at large firms with more than $1 billion in revenue are turning to generative artificial intelligence (GenAI) for complex tasks like production management and cybersecurity.

According to a PYMNTS Intelligence report, “COOs Find the Key for a Positive ROI on GenAI: Customization,” COOs are customizing GenAI to maximize its impact. With expectations for substantial returns on investment by the decade’s end, COOs view GenAI as a key driver of future success.

Expanding Use of GenAI for High-Impact Tasks

COOs are using GenAI for more critical operations, such as production feedback and cybersecurity management. According to the report, there has been significant growth in adoption, with 57% of COOs using GenAI to monitor production in August, up...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Employer, Survey / Study, Technology, Trends
New technique helps LLMs rein in CoT lengths, optimizing reasoning without exploding compute costs
Generative AI and deepfakes are fueling health misinformation. Here's what to look out for so you don't get scammed
Using machine learning tools to detect gene mutations from leukemia cell images
Beyond Documentation: Building Platform Moats in Healthcare AI
OpenAI calls for US to centralize AI regulation

Share This Article